Glaukos Corp. | Ownership
Companies that own Glaukos Corp.
Henderson Global Investors Ltd.
4,871,034
13.82%
-210,405
0.14%
06/30/2018
Capital Research & Management Co. (World Investors)
2,792,481
7.92%
52,481
0.03%
06/30/2018
William Blair Investment Management LLC
2,718,918
7.71%
-135,490
0.34%
06/30/2018
The Vanguard Group, Inc.
2,648,121
7.51%
255,838
0.01%
06/30/2018
T. Rowe Price Associates, Inc.
2,311,342
6.56%
-158,844
0.02%
06/30/2018
BlackRock Fund Advisors
2,234,057
6.34%
361,925
0.01%
06/30/2018
Gilder, Gagnon, Howe & Co. LLC
1,294,902
3.67%
-14,589
0.9%
06/30/2018
Baillie Gifford & Co.
1,211,663
3.44%
92,050
0.05%
06/30/2018
Waddell & Reed Investment Management Co.
1,115,815
3.17%
453,167
0.13%
06/30/2018
Lord, Abbett & Co. LLC
1,074,203
3.05%
922,387
0.19%
06/30/2018
| Address |
229 Avenida Fabricante
San Clemente California 92672
United States
|
|
Employees
|
- |
| Website |
http://www.glaukos.com |
| Updated |
07/08/2019 |
| Glaukos Corp. is an ophthalmic medical device company, which engages in the development and commercialization of surgical devices and sustained pharmaceutical therapies designed to treat glaucoma. Its Micro Invasive Glaucoma Surgery procedures are designed to reduce intraocular eye pressure by improving aqueous outflow through the natural physiologic pathway. The company was founded by Olav B. |
